James A. Schoeneck

2013 - DepoMed

In 2013, James A. Schoeneck earned a total compensation of $2.4M as President and Chief Executive Officer at DepoMed, a 40% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$425,000
Option Awards$674,181
Salary$590,625
Stock Awards$710,850
Other$14,074
Total$2,414,730

Schoeneck received $710.9K in stock awards, accounting for 29% of the total pay in 2013.

Schoeneck also received $425K in non-equity incentive plan, $674.2K in option awards, $590.6K in salary and $14.1K in other compensation.

Rankings

In 2013, James A. Schoeneck's compensation ranked 3,239th out of 12,286 executives tracked by ExecPay. In other words, Schoeneck earned more than 73.6% of executives.

ClassificationRankingPercentile
All
3,239
out of 12,286
74th
Division
Manufacturing
1,097
out of 4,612
76th
Major group
Chemicals And Allied Products
285
out of 1,466
81st
Industry group
Drugs
195
out of 1,160
83rd
Industry
Pharmaceutical Preparations
162
out of 890
82nd
Source: SEC filing on April 14, 2016.

Schoeneck's colleagues

We found four more compensation records of executives who worked with James A. Schoeneck at DepoMed in 2013.

2013

Matthew Gosling

DepoMed

General Counsel

2013

August Moretti

DepoMed

Chief Financial Officer

2013

Thadd Vargas

DepoMed

Senior Vice President, Business Development

2013

Michael Sweeney

DepoMed

Chief Medical Officer

News

You may also like